J.BardJ

Contact your GP or diabetes team if you experience: Persistent nausea or vomiting lasting beyond the first few weeks or preventing adequate food and fluid intake Severe abdominal pain , particularly if persistent or radiating to the backthis could indicate pancreatitis Signs of dehydration from vomiting or diarrhoea, including reduced urination, dizziness, or extreme thirst Recurrent hypoglycaemia (low blood sugar episodes), especially if you're also taking insulin or sulfonylureas Weight loss that is rapid or concerning to you Visual changes or worsening of diabetic eye disease Severe, persistent taste disturbance that affects your nutrition or quality of life significantly Right-sided abdominal pain, fever, or yellowing of the skin or eyes these could indicate gallbladder problems Seek immediate medical attention (call 999 or attend A&E) if you develop: Severe, persistent abdominal pain with or without vomiting stop taking Rybelsus immediately if pancreatitis is suspected Signs of a severe allergic reaction (difficulty breathing, facial swelling, severe rash) Symptoms of severe hypoglycaemia (confusion, loss of consciousness, seizures) Your healthcare provider can assess whether side effects are likely to improve with time, whether dose adjustment might help, or whether an alternative medication would be more appropriate

Increased energy is often the first noticeable change, followed by gradual improvements in body composition over subsequent weeks
Mavroson urges patients to have an open discussion with their provider about any potential serious risks or side effects that could occur while using a GLP-1
Bianca Sculpt & Restore: EvolveX
Start your intake GLP-1 Medications Currently Available in Canada Semaglutide (Ozempic for diabetes, Wegovy for weight management) and tirzepatide (Mounjaro for diabetes) are Health Canada-approved and available via prescription